Nalaganje...
Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity
BACKGROUND: Persons infected with HIV often have altered lipid profiles that may be affected by antiretroviral therapies (ART). Traditional lipid measurements may be insufficient to assess cardiovascular disease (CVD) risk in this population. METHODS: We report results from 39 ART-naive participants...
Shranjeno v:
| izdano v: | Antivir Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5516727/ https://ncbi.nlm.nih.gov/pubmed/27740536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3091 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|